This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Illumina Inc (ILMN)

NASDAQ: Health Care

$140.71 +1.81 | 1.30%
05/06/16 - 3:59:00 PM ET
  • Prev Close: 138.90
  • Day's Open: 138.55
  • Volume: 2.21M
  • Avg Vol: 1.54M
  • Shares Outstanding: 147.00M
  • Mkt Cap: 19.84B
  • Div: --
  • Div Yield: --
  • P/E: 46.54
  • EPS: 3.20
ILMN Day's Range
$138.03
$142.78
ILMN 52 Week Range
$127.10
$242.37
Trade Now:
ILMN Business Summary
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company's sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes.View ILMN key stats
Illumina Inc - ILMN - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Illumina Inc as a Buy with a ratings score of B-.
Report Snippet: We rate ILLUMINA INC (ILMN) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself.
Rating: 3.33 out of 5, 'B-' Buy.
You can view the full analysis from the report here:
ILMN Rating Report
ILMN Earnings Transcripts
  • Illumina (ILMN) Earnings Report: Q1 2016 Conference Call Transcript
    TheStreet | 05/05/16 - 04:58 AM EDT
  • Illumina (ILMN) Earnings Report: Q4 2015 Conference Call Transcript
    TheStreet | 02/03/16 - 09:03 AM EST
  • Illumina (ILMN) Earnings Report: Q3 2015 Conference Call Transcript
    TheStreet | 10/21/15 - 07:45 AM EDT
  • Illumina (ILMN) Earnings Report: Q2 2015 Conference Call Transcript
    TheStreet | 07/22/15 - 08:39 AM EDT
ILMN Performance as of Prev. Close
YTD
-27.64%
3-Mo
2.09%
1-Yr
-25.74%
3-Yr
113.99%
ILMN EPS Performance
1-Yr Ago
3.20
2-Yrs Ago
2.60
3-Yrs Ago
1.00
ILMN Percentage in these ETFs
0.140%
0.110%
0.048%
0.029%
0.020%
ILMN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for ILMN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 7 7 9
Moderate Buy 0 0 0 0
Hold 11 9 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ILMN ANALYST REPORT

ILMN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs